RxDoctor Payments Data

Becky Watson

Psychiatric/Mental Health · Morehead, KYNPI 1760116081

Payments from drug & device makers

$709in general payments, 2019–2025

Across 35 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$140
  • Teva Pharmaceuticals USA, Inc.$125
  • AbbVie$122
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$67
  • Otsuka America Pharmaceutical, Inc.$55
  • Alkermes, Inc.$48
  • plus $152 from 5 others

What the payments were for

  • Food & beverage$709100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$709 in reported general payments places this provider in the 45th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$8,311
Medicare patients
34
Services billed
104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate17$134,162
VraylarCariprazine Hcl14$16,312
Aripiprazole27$9,583
Asenapine Maleate12$5,879
Bupropion XlBupropion Hcl77$5,107
Quetiapine Fumarate ErQuetiapine Fumarate20$2,063
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl28$1,538
Duloxetine Hcl108$1,363
Quetiapine Fumarate39$1,282
Oxcarbazepine30$1,156
Mirtazapine69$1,153
Doxepin Hcl23$1,106
Trazodone Hcl91$1,059
Venlafaxine Hcl ErVenlafaxine Hcl37$993
Hydroxyzine Hcl61$839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$46$134,16217 claims
AbbVieVraylar$122$16,31214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Morehead

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →